Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NeoGenomics Inc. Common Stock (NEO) vs Exxon Mobil Corporation (XOM) Price & Performance

NeoGenomics Inc. Common StockTrade
Exxon Mobil CorporationTrade

Price performance (Past 24H)

Key statistics

NeoGenomics Inc. Common Stock vs Exxon Mobil Corporation — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Exxon Mobil Corporation trades at $178.39 (market cap $727.85B). The key difference: Exxon Mobil Corporation is far larger — about 335.4× NeoGenomics Inc. Common Stock's market cap, and Exxon Mobil Corporation pays a 2.33% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Exxon Mobil Corporation for 100 Days on average.

NEOXOM
Market Cap
$2.17B$727.85B
Volume
1,615,94310,493,203
Sector
HealthEnergy
52-Week High
$19.91$177.06
52-Week Low
$7.19$110.64
Typical Hold Time
0 Days100 Days
Enterprise Value
$2.47B$759.63B
Dividend Yield
—2.33%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Exxon Mobil Corporation

ExxonMobil (XOM) trades at $174.13, up 1.15% with a bullish technical signal from moving averages. The company maintains strong profitability with 9.07% net margin and 12.55% ROE, though revenue declined to $323.91B in 2025. Recent developments include negotiations to return to Venezuela's oil fields and expansion in Guyana and Permian Basin assets targeting 5.5 MMBoe/d production by 2030.

XOM presents a mixed outlook with analyst consensus at Hold (56.37%) and $166.67 price target below current levels. Upside potential exists from strategic expansions and LNG market growth, but risks include declining revenue trends, geopolitical exposure in Venezuela, and refinery operational challenges. The stock trades near resistance at $174 with RSI indicating overbought conditions.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEO
100% Buy0% Sell
Avg holding period · 0 Days
XOM
74% Buy26% Sell
Avg holding period · 100 Days

Top news

Latest headlines on both assets

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →

About Exxon Mobil Corporation

Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.

Read more on XOM →